First Report Cfr and Optr A Co-harboring Linezolid-Resistant Enterococcus faecalis in China

Qingqing Chen1,2, Dandan Yin1,3, Pei Li1,3

  • 1Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.

Insights

A linezolid-resistant Enterococcus faecalis strain with optrA and cfr genes was identified in China. These resistance genes were located on separate plasmids and transferable, leading to increased resistance to linezolid and chloramphenicol.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Antimicrobial Resistance

Background:

  • Enterococcus faecalis is a significant opportunistic pathogen.
  • Emergence of resistance to last-resort antibiotics like linezolid is a growing global health concern.
  • The cfr and optrA genes are known mechanisms conferring resistance to phenicol and oxazolidinone antibiotics.

Purpose of the Study:

  • To characterize a clinical isolate of Enterococcus faecalis resistant to linezolid.
  • To investigate the genetic basis and transferability of the optrA and cfr resistance genes.
  • To report the first co-occurrence of optrA and cfr in a clinical E. faecalis strain in China.

Main Methods:

  • Isolation and identification of the E. faecalis strain.
  • Antimicrobial susceptibility testing (MIC determination).
  • Plasmid analysis, gene sequencing, and bacterial conjugation experiments.

Main Results:

  • A linezolid-resistant E. faecalis strain was isolated, lacking mutations in common resistance loci.
  • The optrA and cfr genes were identified and found to be located on two distinct, transferable plasmids.
  • Transfer of these plasmids to a recipient strain conferred resistance to linezolid and chloramphenicol.

Conclusions:

  • The co-harboring of optrA and cfr on separate plasmids in E. faecalis represents a novel mechanism for multidrug resistance.
  • The transferability of these plasmids highlights the potential for rapid dissemination of antibiotic resistance.
  • This finding underscores the need for enhanced surveillance of antibiotic resistance in clinical settings in China.